Bath & Body Works' (BBWI) Hold (C-) Rating Reaffirmed at Weiss Ratings

Key Points

• Bath & Body Works (BBWI) received a "hold (C-)" rating from Weiss Ratings, reaffirming analysts' cautious stance on the stock as several other analysts have adjusted their price targets downward.
• Shares of BBWI increased by 1.4% to $26.03, with significant trading volume exceeding their average, indicating potential investor interest amid recent mixed evaluations.
• The company reported quarterly earnings of $0.37 EPS, meeting expectations, but experienced a 0.8% decline in revenue compared to the previous year.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "hold (c-)" rating reiterated by analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

A number of other analysts have also commented on BBWI. Citigroup cut their price target on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. UBS Group lowered their price objective on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday, August 29th. Morgan Stanley lowered their price objective on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a research report on Friday, September 12th. Finally, Barclays raised their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Eleven investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $38.15.

Bath & Body Works Stock Up 1.4%

Shares of BBWI stock traded up $0.35 during mid-day trading on Wednesday, reaching $26.03. 7,094,168 shares of the stock traded hands, compared to its average volume of 5,509,985. The stock's fifty day simple moving average is $28.22 and its two-hundred day simple moving average is $29.41. Bath & Body Works has a 1-year low of $24.93 and a 1-year high of $41.87. The company has a market cap of $5.37 billion, a price-to-earnings ratio of 7.72, a price-to-earnings-growth ratio of 0.90 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the firm posted $0.37 earnings per share. The business's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities research analysts anticipate that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Parkside Financial Bank & Trust boosted its position in shares of Bath & Body Works by 24.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company's stock valued at $55,000 after buying an additional 364 shares during the last quarter. Parallel Advisors LLC boosted its position in shares of Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock valued at $37,000 after buying an additional 481 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Bath & Body Works by 15.5% during the first quarter. Blue Trust Inc. now owns 4,184 shares of the company's stock valued at $127,000 after buying an additional 560 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after buying an additional 596 shares during the last quarter. Finally, Natixis Advisors LLC boosted its position in shares of Bath & Body Works by 0.7% during the first quarter. Natixis Advisors LLC now owns 90,089 shares of the company's stock valued at $2,732,000 after buying an additional 629 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.